Cytek Biosciences, Inc. (CTKB)
USD 6.24
(-2.95%)
USD 6.24
(-2.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 5.28 Million | -12.23 Million | 4.63 Million | 15.15 Million | -13.74 Million |
| Net Income | -12.14 Million | 2.48 Million | 3.02 Million | 19.41 Million | -16.82 Million |
| Depreciation & Amortization | 9.23 Million | 5.65 Million | 1.24 Million | 603 Thousand | 309 Thousand |
| Deferred income taxes | 4.83 Million | - | 448 Thousand | 1.74 Million | - |
| Stock-based compensation | 22.04 Million | 16.59 Million | 6.58 Million | 611 Thousand | 269 Thousand |
| Change in working capital | -10.5 Million | -39.92 Million | -8.64 Million | -7.53 Million | 1.15 Million |
| Other non-cash items | -8.17 Million | 2.95 Million | 1.97 Million | 323 Thousand | 1.34 Million |
| Investing Cash Flow | -93.89 Million | -55.9 Million | -20.99 Million | -1.54 Million | -973 Thousand |
| Investments in PPE | -4.82 Million | -9.86 Million | -4.36 Million | -1.54 Million | -973 Thousand |
| Acquisitions | -45.13 Million | - | -16.62 Million | - | - |
| Investment purchases | -175.93 Million | -46.04 Million | - | - | - |
| Sales/Maturities of investments | 132 Million | - | - | - | - |
| Other Investing Activities | -44.11 Million | -46.16 Million | 371 Thousand | - | - |
| Financing Cash Flow | -41.81 Million | 5.51 Million | 213.55 Million | 122.6 Million | 93 Thousand |
| Debt repayment | -565 Thousand | -50 Thousand | -2.77 Million | -1.31 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -44.15 Million | -209 Thousand | - | - | - |
| Common Stock Issuance | 1.46 Million | 1.2 Million | 215.68 Million | 119.83 Million | 93 Thousand |
| Other Financing Activities | 2.9 Million | 4.77 Million | 642 Thousand | 4.08 Million | 93 Thousand |
| Accounts receivables | -7.33 Million | -19.74 Million | -12.36 Million | 334 Thousand | -12.61 Million |
| Accounts payables | -1.78 Million | 1.86 Million | -256 Thousand | -55 Thousand | 1.21 Million |
| Inventory | 4.28 Million | -17.65 Million | -7.06 Million | -5.7 Million | -14.61 Million |
| Other working capital | -5.67 Million | -4.39 Million | 11.04 Million | -2.11 Million | 27.17 Million |
| Cash at beginning of period | 299.5 Million | 364.61 Million | 166.11 Million | 30.49 Million | 45.15 Million |
| Cash at end of period | 167.63 Million | 299.5 Million | 364.61 Million | 166.11 Million | 30.49 Million |
| Capital Expenditure | -4.82 Million | -9.86 Million | -4.36 Million | -1.54 Million | -973 Thousand |
| Effect of forex changes on cash | -1.44 Million | -2.49 Million | 1.3 Million | -587 Thousand | -33 Thousand |
| Net cash flow / Change in cash | -131.87 Million | -65.11 Million | 198.49 Million | 135.62 Million | -14.66 Million |
| Free Cash Flow | 454 Thousand | -22.09 Million | 266 Thousand | 13.6 Million | -14.72 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.43 Million | -6.16 Million | 5.5 Million | -12.14 Million | -6.45 Million | -4.38 Million |
| Depreciation & Amortization | 2.48 Million | 2.46 Million | 2.42 Million | 9.23 Million | 2.55 Million | 2.44 Million |
| Deferred income taxes | - | - | -5.71 Million | 4.83 Million | 2.98 Million | -2.02 Million |
| Stock-based compensation | 7.15 Million | 5.64 Million | 5.66 Million | 22.04 Million | 5.75 Million | 5.92 Million |
| Change in working capital | 8.1 Million | 1.84 Million | -3.83 Million | -10.5 Million | -5.26 Million | -5.09 Million |
| Other non-cash items | 1.18 Million | 1.11 Million | 5.47 Million | -8.17 Million | -3.81 Million | 287 Thousand |
| Investing Cash Flow | 2.02 Million | -5.75 Million | 29.06 Million | -93.89 Million | 43.12 Million | 2.79 Million |
| Investments in PPE | -1.2 Million | -622 Thousand | -1.56 Million | -4.82 Million | -1.39 Million | -1.36 Million |
| Acquisitions | 76 Thousand | - | -236 Thousand | -45.13 Million | -1000.00 | -10 Million |
| Investment purchases | -36.85 Million | -77.13 Million | -23.13 Million | -175.93 Million | -23.48 Million | -5.84 Million |
| Sales/Maturities of investments | 40 Million | 72 Million | 54 Million | 132 Million | 68 Million | 10 Million |
| Other Investing Activities | 3.07 Million | -55 Thousand | 30.56 Million | -44.11 Million | 44.69 Million | 10 Million |
| Financing Cash Flow | -1.71 Million | 1.61 Million | -33.75 Million | -41.81 Million | -8.27 Million | 216 Thousand |
| Debt repayment | -142 Thousand | -1.25 Million | -140 Thousand | -565 Thousand | -138 Thousand | -141 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -2.67 Million | -148 Thousand | -34.74 Million | -44.15 Million | -8.42 Million | -981 Thousand |
| Common Stock Issuance | 1.23 Million | 506 Thousand | -1.12 Million | 1.46 Million | 441 Thousand | 483 Thousand |
| Other Financing Activities | -130 Thousand | -148 Thousand | 2.25 Million | 2.9 Million | 292 Thousand | 1.35 Million |
| Accounts receivables | 5.91 Million | 4.23 Million | 263 Thousand | -7.33 Million | -6.85 Million | -6.8 Million |
| Accounts payables | -519 Thousand | 615 Thousand | -1.79 Million | -1.78 Million | 1.7 Million | -2 Million |
| Inventory | 4.42 Million | 4.77 Million | 6.33 Million | 4.28 Million | -1.88 Million | 3.02 Million |
| Other working capital | -1.71 Million | -7.77 Million | -8.64 Million | -5.67 Million | 1.76 Million | 681 Thousand |
| Cash at beginning of period | 169.14 Million | 167.63 Million | 163.62 Million | 299.5 Million | 131.54 Million | 132.39 Million |
| Cash at end of period | 177.91 Million | 169.14 Million | 167.63 Million | 167.63 Million | 163.62 Million | 131.54 Million |
| Capital Expenditure | -1.2 Million | -622 Thousand | -1.56 Million | -4.82 Million | -1.39 Million | -1.36 Million |
| Effect of forex changes on cash | 2.26 Million | 1.69 Million | -823 Thousand | -1.44 Million | 1.47 Million | -1 Million |
| Net cash flow / Change in cash | 8.77 Million | 1.51 Million | 4 Million | -131.87 Million | 32.08 Million | -850 Thousand |
| Free Cash Flow | 5 Million | 3.33 Million | 7.95 Million | 454 Thousand | -5.63 Million | -4.21 Million |
KHADIM
SULA
EWTX
ARVSMART
4062
APP